Photo by sharonmccutcheon from unsplash
Plasma uric acid (UA) has been proposed as a biomarker of cardiovascular (CV) risk, but data are limited. UA levels may also modulate the effectiveness of CV risk reduction therapies.… Click to show full abstract
Plasma uric acid (UA) has been proposed as a biomarker of cardiovascular (CV) risk, but data are limited. UA levels may also modulate the effectiveness of CV risk reduction therapies. In EMPA-REG OUTCOME, patients (N=7020) with type 2 diabetes (T2D) and CV disease were treated with empagliflozin 10
Keywords:
association uric;
reg outcome;
uric acid;
type diabetes;
empa reg
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!